| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 37.9× | −1.7× | |
| Price / Book | 4.8× | 2.0× | |
| Price / Sales | 5.7× | 3.9× | |
| Price / Free cash flow | 40.5× | −1.6× | |
| EV / EBITDA | 25.0× | −1.2× | |
| Earnings yield | 2.6% | −14.6% | |
| Free cash flow yield | 2.5% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,249.81 | −0.57% | $1.18T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $254.30 | −0.49% | $612.84B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.75 | −0.59% | $501.42B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $406.15 | +1.18% | $364.56B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.16 | −1.23% | $355.67B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.45 | −0.11% | $278.32B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.49 | −0.56% | $255.11B | 25.0× | 21.1% | −2.2% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $426.75 | −1.33% | $230.71B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.23 | −1.25% | $191.24B | 22.8× | 37.5% | +32.0% |
ABNYSE:ABTAbbott Laboratories · 🇺🇸 NYSE | $104.11 | −0.75% | $181.33B | 28.0× | 12.5% | −19.0% |
